Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7341)
All Articles published online
|
Publishing Process of This Article
|
Jul 14, 2017 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Latt NL, Yanny BT, Gharibian D, Gevorkyan R, Sahota AK. Eight-week ledipasvir/sofosbuvir in non-cirrhotic, treatment-naïve hepatitis C genotype-1 patients with hepatitis C virus-RNA < 6 million: Single center, real world effectiveness and safety. World J Gastroenterol 2017; 23(26): 4759-4766 [PMID: 28765697 DOI: 10.3748/wjg.v23.i26.4759] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v23/i26/4759.htm |
| Number | Citing Articles |
| 1 |
Ashly Maughan, Onyema Ogbuagu. Pegylated interferon alpha 2a for the treatment of hepatitis C virus infection. Expert Opinion on Drug Metabolism & Toxicology 2018; 14(2): 219 doi: 10.1080/17425255.2018.1421173
|
| 2 |
Trung Cao, Natalia Dyatkina, Sébastien Lemaire, Marija Prhavc, Simon Wagschal. Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry. Volume 4. ACS Symposium Series 2022; 1423: 95 doi: 10.1021/bk-2022-1423.ch002
|
| 3 |
Massimo Giuseppe Colombo, Erkin Isakovich Musabaev, Umed Yusupovich Ismailov, Igor A Zaytsev, Alexander V Nersesov, Igor Anatoliyevich Anastasiy, Igor Alexandrovich Karpov, Olga A Golubovska, Kulpash S Kaliaskarova, Ravishankar AC, Sanjay Hadigal. Consensus on management of hepatitis C virus infection in resource-limited Ukraine and Commonwealth of Independent States regions. World Journal of Gastroenterology 2019; 25(29): 3897-3919 doi: 10.3748/wjg.v25.i29.3897
|
| 4 |
Christopher R. Jones, Barnaby F. Flower, Ella Barber, Bryony Simmons, Graham S. Cooke. Treatment optimisation for hepatitis C in the era of combination direct-acting antiviral therapy: a systematic review and meta-analysis. Wellcome Open Research 2019; 4: 132 doi: 10.12688/wellcomeopenres.15411.1
|
| 5 |
Jieun Lee, Sang Bong Ahn, Sun Young Yim, Jihyun An, Dae Won Jun, Min Jung Ko, Dong Ah Park, Jeong‐Ju Yoo. Efficacy and safety of direct‐acting antiviral therapy for hepatitis C virus in elderly patients (≥65 years old): A systematic review and meta‐analysis. Journal of Viral Hepatitis 2022; 29(7): 496 doi: 10.1111/jvh.13679
|
| 6 |
Beshoy Yanny, Sammy Saab, Francisco Durazo, Nyan Latt, Amanda Mitry, Mira Moris Mikhail, Ramy M. Hanna, Antony Aziz, Amandeep Sahota. Eight-Week Hepatitis C Treatment with New Direct Acting Antivirals Has a Better Safety Profile While Being Effective in the Treatment-Naïve Geriatric Population Without Liver Cirrhosis and Hepatitis C Virus-RNA < 6 Million IU/mL. Digestive Diseases and Sciences 2018; 63(12): 3480 doi: 10.1007/s10620-018-5283-1
|
| 7 |
Hyejin Lee, Dnyandev B. Jarhad, Jinha Yu, Choongho Lee, Lak Shin Jeong. Asymmetric Synthesis of 2′-C-Methyl-4′-selenonucleosides as Anti-Hepatitis C Virus Agents. The Journal of Organic Chemistry 2019; 84(22): 14414 doi: 10.1021/acs.joc.9b01462
|
| 8 |
Guangyi Wang, Natalia Dyatkina, Marija Prhavc, Caroline Williams, Vladimir Serebryany, Yujian Hu, Yongfei Huang, Xiangyang Wu, Tongqian Chen, Wensheng Huang, Vivek K. Rajwanshi, Jerome Deval, Amy Fung, Zhinan Jin, Antitsa Stoycheva, Kenneth Shaw, Kusum Gupta, Yuen Tam, Andreas Jekle, David B. Smith, Leonid Beigelman. Synthesis and Anti-HCV Activity of Sugar-Modified Guanosine Analogues: Discovery of AL-611 as an HCV NS5B Polymerase Inhibitor for the Treatment of Chronic Hepatitis C. Journal of Medicinal Chemistry 2020; 63(18): 10380 doi: 10.1021/acs.jmedchem.0c00935
|
| 9 |
Soon Kyu Lee, Sung Won Lee, Hae Lim Lee, Hee Yeon Kim, Chang Wook Kim, Do Seon Song, U Im Chang, Jin Mo Yang, Sun Hong Yoo, Jung Hyun Kwon, Soon Woo Nam, Seok-Hwan Kim, Myeong Jun Song, Jaejun Lee, Hyun Yang, Si Hyun Bae, Ji Won Han, Heechul Nam, Pil Soo Sung, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon. Real-life experience of ledipasvir and sofosbuvir for HCV infected Korean patients: a multicenter cohort study. The Korean Journal of Internal Medicine 2022; 37(6): 1167 doi: 10.3904/kjim.2022.013
|
| 10 |
Guangyi Wang, Natalia Dyatkina, Marija Prhavc, Caroline Williams, Vladimir Serebryany, Yujian Hu, Yongfei Huang, Jinqiao Wan, Xiangyang Wu, Jerome Deval, Amy Fung, Zhinan Jin, Hua Tan, Kenneth Shaw, Hyunsoon Kang, Qingling Zhang, Yuen Tam, Antitsa Stoycheva, Andreas Jekle, David B. Smith, Leonid Beigelman. Synthesis and Anti-HCV Activities of 4′-Fluoro-2′-Substituted Uridine Triphosphates and Nucleotide Prodrugs: Discovery of 4′-Fluoro-2′-C-methyluridine 5′-Phosphoramidate Prodrug (AL-335) for the Treatment of Hepatitis C Infection. Journal of Medicinal Chemistry 2019; 62(9): 4555 doi: 10.1021/acs.jmedchem.9b00143
|
| 11 |
Lone W. Madsen, Peer B. Christensen, Janne F. Hansen, Birgit T. Røge, Dorte K. Holm, Sandra Dröse, Anne Øvrehus. Four Weeks Treatment with Glecaprevir/Pibrentasvir + Ribavirin—A Randomized Controlled Clinical Trial. Viruses 2022; 14(3): 614 doi: 10.3390/v14030614
|
| 12 |
Z. M. Younossi, A. Tanaka, Y. Eguchi, L. Henry, R. Beckerman, M. Mizokami. Treatment of hepatitis C virus leads to economic gains related to reduction in cases of hepatocellular carcinoma and decompensated cirrhosis in Japan. Journal of Viral Hepatitis 2018; 25(8): 945 doi: 10.1111/jvh.12886
|
| 13 |
Rosanna Villani, Matteo Monami, Francesca Di Cosimo, Gilda Fioravanti, Edoardo Mannucci, Gianluigi Vendemiale, Gaetano Serviddio. Direct‐acting antivirals for HCV treatment in older patients: A systematic review and meta‐analysis. Journal of Viral Hepatitis 2019; 26(11): 1249 doi: 10.1111/jvh.13169
|
| 14 |
Zuqiang Fu, Chen Dong, Zhijun Ge, Chunhui Wang, Yun Zhang, Chao Shen, Jun Li, Chuanlong Zhu, Yan Wang, Peng Huang, Ming Yue. High SVR12 With 8-Week Course of Direct-Acting Antivirals in Adolescents and Children With Chronic Hepatitis C: A Comprehensive Analysis. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.608760
|
| 15 |
Ameer Abutaleb, Shyam Kottilil, Eleanor Wilson. Glecaprevir/pibrentasvir expands reach while reducing cost and duration of hepatitis C virus therapy. Hepatology International 2018; 12(3): 214 doi: 10.1007/s12072-018-9873-y
|
| 16 |
Rohit P. Ojha, Brooke R. MacDonald, Tzu-Chun Chu, Julia L. Marcus. Potential Overestimation of Racial Disparities in Response to the 8-Week Ledipasvir/Sofosbuvir Regimen for Hepatitis C Virus Genotype 1 Infection. Gastroenterology 2018; 155(5): 1646 doi: 10.1053/j.gastro.2018.07.044
|